Bryan Haugen, MD
Endocrinology, Diabetes and Metabolism
Locations
Practice Locations
UCHealth Diabetes and Endocrinology Clinic - Anschutz Medical Campus
720-848-2650
UCHealth Thyroid Cancer Multidisciplinary Clinic - Anschutz Medical Campus
720-848-3299
UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
720-848-0000
Provider Expertise
Clinical Interest for Patients
I am interested in thyroid disease, thyroid nodules, thyroid cancer, pituitary disorders and adrenal disease.
Specialties
- Internal Medicine
- Endocrinology, Diabetes and Metabolism ( 1993 )
Conditions & Treatments
-
Endocrine System (Hormones)
Endocrine Cancer (Parathyroid, Adrenal, Carcinoid), Thyroid Cancer, Thyroid Disease
Education & Training
Medical Schools
MD, Mayo Medical School (1987)
Undergraduate Schools
BA, Saint Olaf College (MN) (1981)
Internships
University of Colorado (1988)
Residency Program
University of Colorado (1990)
Fellowships
University of Colorado (1993)
Professional Memberships
American Association for Cancer Research, Member
American Association of Clinical Endocrinologists (AACE), Member
American College of Physicians (ACP), Fellow
American Thyroid Association (ATA) , Member
Association of American Physicians, Member
Endocrine Society, Member
Research & Grants
Grants
Two NIH Grants on molecular mechanisms of thyroid cancer progression and therapy (2013)
Research Interests for Patients
My research focuses on molecular studies of thyroid diseases and endocrine neoplasms.
information for referring providers
Referral Contact Phone
(720) 848-2650
Referral Contact Fax
720-848-2653
Clinical Interests for Referring Providers
My current current clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction and other endocrine tumors (parathyroid, adrenal, carcinoid).
Research Interest for Referring Providers
My research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets. Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms. My research group is also actively studying novel regulation of the hypothalamic-pituitary-thyroid axis.
